Revision of Exelixis
syncWikidata syncChanges
| Field | Before | After |
|---|---|---|
image_id | — | 199819 |
description | — | Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. |
entity_type | — | organization |